|
| Press Releases |
|
 |
|
| Friday, March 21, 2025 |
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
| On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
| Friday, February 14, 2025 |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| more info >> |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
| Friday, January 24, 2025 |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| more info >> |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
| Thursday, January 9, 2025 |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
| Monday, December 9, 2024 |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
| Monday, December 2, 2024 |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
Jun 11, 2025 14:31: JST
|
|
|
英國國防部與通用原子航空系統公司簽署「保護者」支援合約
Jun 11, 2025 13:00 HKT/SGT
|
|
|
英国国防部与通用原子航空系统公司签署“保护者”支持合同
Jun 11, 2025 12:58 HKT/SGT
|
|
|
三菱重工、バイオエタノールを活用したクリーン燃料の製造技術を開発するiPEACE223社に出資
Jun 11, 2025 11:40: JST
|
|
|
Blockpass partners with CryptoSwift to deliver global Travel Rule Compliance
Jun 11, 2025 10:00 HKT/SGT
|
|
|
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London
Jun 11, 2025 09:21 HKT/SGT
|
|
|
爆款IPO前瞻：「香水第一股」穎通控股強勢登場！港股IPO再現黃金賽道 龍頭勢掀「嗅覺經濟」新浪潮
Jun 10, 2025 19:10 HKT/SGT
|
|
|
爆款IPO前瞻：“香水第一股”颖通控股强势登场！港股IPO再现黄金赛道 龙头势掀“嗅觉经济”新浪潮
Jun 10, 2025 19:10 HKT/SGT
|
|
|
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
Jun 10, 2025 19:47 JST
|
|
|
ダイムラートラック、三菱ふそう、日野、トヨタ、三菱ふそうと日野の統合に関する最終合意を締結
Jun 10, 2025 16:30: JST
|
|
|
聯想控股副總裁于浩：在技術變革中錨定「長期主義」
Jun 10, 2025 15:37 HKT/SGT
|
|
|
联想控股副总裁于浩：在技术变革中锚定"长期主义"
Jun 10, 2025 15:28 HKT/SGT
|
|
|
Ai sẽ là người đầu tiên ghi danh vào lịch sử với tư cách là Nhà Vô Địch Thế Giới đầu tiên?!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir nama dalam sejarah sebagai "Juara Dunia Pertama"!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir namanya dalam sejarah sebagai “Juara Dunia Pertama”!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
